Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Marc Trossaert"'
Autor:
Aurélie Briane, Valérie Horvais, Marianne Sigaud, Marc Trossaërt, Nicolas Drillaud, Catherine Ternisien, Marc Fouassier, Antoine Babuty
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 964-970 (2024)
Abstract Treatment of type 3 von Willebrand disease by infusion of von Willebrand factor (VWF) and factor VIII (FVIII) concentrates may lead to the development of anti‐VWF antibodies, challenging haemostasis management. The systematic review of the
Externí odkaz:
https://doaj.org/article/d6a73bb4dec94851b6773375cd734b50
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTObjectives: To describe clinical characteristics, factor consumption, and events of interest in patients with haemophilia A without inhibitors receiving prophylaxis in France, and the clinical impact of switching to Elocta® in this populatio
Externí odkaz:
https://doaj.org/article/9a278d964606439d873d08d43e64581f
Autor:
Ngoc Anh Thu Nguyen, Pascal Auquier, Any Beltran Anzola, Roseline D’oiron, Thierry Lambert, Céline Falaise, Christine Biron, Anne Lienhart, Jenny Goudemand, Antoine Rauch, Bénédicte Wibaut, Sabine Marie Castet, Dominique Desprez, Annie Harroche, Natalie Stieltjes, Annie Borel-Derlon, Marc Trossaërt, Amandine Celli, Benoît Guillet, Sophie Bayart, Marie-Anne Bertrand, Alexandra Fournel, Guillaume Mourey, Valérie Gay, Pierre Chamouni, Emmanuelle DE Raucourt, Birgit Frotscher, Michèle Martin, Mathieu Puyade, Brigitte Tardy, Stéphane Vanderbecken, Fabienne Genre-Volot, Philippe Nguyen, Benoît Polack, Caroline Oudot-Challard, Stéphane Girault, Annelise Voyer, Aurélien Lebreton, Abel Hassoun, Philippe Moreau, Pierre-Simon Rohrlich, Karine Baumstarck, Mohamed Boucekine, Vanessa Milien, Natacha Rosso, Clemence Tabele, Marie Viprey, Nicolas Giraud, Thomas Sannie, Hervé Chambost, Noémie Resseguier
Publikováno v:
HemaSphere, Vol 7, p e623777c (2023)
Externí odkaz:
https://doaj.org/article/35f0ccb00974432f92e9847dd92e5503
Autor:
Marc Trossaert, Valerie Chamouard, Christine Biron‐Andreani, Alessandro Casini, Philippe De Mazancourt, Emmanuelle De Raucourt, Nicolas Drillaud, Birgit Frotscher, Benoit Guillet, Aurelien Lebreton, Valerie Roussel‐Robert, Lucia Rugeri, Yesim Dargaud
Publikováno v:
European Journal of Haematology. 110:584-601
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d296361f23ff5bdb000e7d77a168c35a
https://doi.org/10.1111/ejh.13941
https://doi.org/10.1111/ejh.13941
Autor:
Brigitte Tardy, Thierry Lambert, Pierre Chamouni, Aurélie Montmartin, Marc Trossaert, Ségolène Claeyssens, Claire Berger, Laurent Ardillon, Valérie Gay, Xavier Delavenne, Annie Harroche, Pierre Chelle
Publikováno v:
Haemophilia. 28:542-547
Nonacog alfa, a standard half-life recombinant factor IX (FIX), is used as a prophylactic treatment in severe haemophilia B (SHB) patients. Its half-life determined in clinical studies involving a limited sampling (72 h) was shown to be rather short.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ab662c0787a5a1d252576cb05669f0
https://doi.org/10.1111/hae.14560
https://doi.org/10.1111/hae.14560
Autor:
Alban Fouasson-Chailloux, Fabien Leboeuf, Yves Maugars, Marc Trossaert, Pierre Menu, François Rannou, Claire Vinatier, Jérome Guicheux, Raphael Gross, Marc Dauty
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 12; Pages: 7527
Some patients with moderate haemophilia (PWMH) report joint damage potentially responsible for gait disorders. Three-dimensional gait analysis (3DGA) is a relevant tool for the identification of complex musculoskeletal impairment. We performed an eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297162d8dbd61938dbe00318243c7a9c
https://usir.salford.ac.uk/id/eprint/64461/1/PMC9223556.pdf
https://usir.salford.ac.uk/id/eprint/64461/1/PMC9223556.pdf
Autor:
Philippe Beurrier, Nicolas Drillaud, Marc Trossaert, Olivier Feugeas, Emmanuelle de Raucourt, Anamaria Callegarin, Claire Flaujac, Yoann Pailler, Fabienne Volot, Dominique Desprez, Vincent Cussac, Brigitte Pan-Petesch
Publikováno v:
Haemophilia. 27:270-276
Introduction Von Willebrand Disease is a common inherited haemorrhagic disorder due to a deficiency of Von Willebrand Factor (VWF). In case of surgical procedures in patients who are not responsive or have contraindications to desmopressin, replaceme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c5a2f303283f193b7bbada9372fe853
https://doi.org/10.1111/hae.14242
https://doi.org/10.1111/hae.14242
Autor:
Maria Teresa Pagliari, Frits R. Rosendaal, Minoo Ahmadinejad, Zahra Badiee, Mohammad‐Reza Baghaipour, Luciano Baronciani, Olga Benítez Hidalgo, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Renato Marino, Johannes Oldenburg, Ian Peake, Cristina Santoro, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Hamideh Yadegari, Eva M.K. Zetterberg, Flora Peyvandi, Augusto B. Federici, Jeroen Eikenboom
Publikováno v:
Journal of Thrombosis and Haemostasis, 20(5), 1106-1114. WILEY
Journal of Thrombosis and Haemostasis, 20(5), 1106-1114. Wiley-Blackwell Publishing Ltd
Journal of Thrombosis and Haemostasis, 20(5), 1106-1114. Wiley-Blackwell Publishing Ltd
Background\ud \ud Type 3 von Willebrand disease (VWD) is a severe bleeding disorder caused by the virtually complete absence of von Willebrand factor (VWF). Pathophysiological mechanisms of VWD like defective synthesis, secretion, and clearance of VW
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d842656b347c2e973e2fd7704d87b9
https://hdl.handle.net/1887/3307282
https://hdl.handle.net/1887/3307282
Autor:
Anne Goodeve, Marc Trossaert, Ulrich Budde, Frank W.G. Leebeek, Riitta Lassila, Gholamreza Toogeh, Peyman Eshghi, Flora Peyvandi, Jeroen Eikenboom, Renato Marino, Cristina Santoro, Eva Zetterberg, Bijan Keikhaei, Andreas Tiede, Nikolas Nikšić, Imre Bodó, Minoo Ahmadinejad, Giancarlo Castaman, Alberto Tosetto, Ian R. Peake, Jenny Goudemand, Olga Benitez, Augusto B. Federici, Pier Mannuccio Mannucci, Mehran Karimi, Maria Fernanda Lopez Fernandez, Luciano Baronciani, Wolf A Hassenpflug, Florian Oyen, Hamid Hoorfar, Andrea Cairo, Zahra Badiee, Reinhard Schneppenheim, Mohammad-Reza Baghaipour
Publikováno v:
Blood Adv
Blood advances, 5(15), 2987-3001. American Society of Hematology
Blood Advances, 5(15), 2987-3001. ELSEVIER
Blood advances, 5(15), 2987-3001. American Society of Hematology
Blood Advances, 5(15), 2987-3001. ELSEVIER
Type 3 von Willebrand disease (VWD3) is a rare and severe bleeding disorder characterized by often undetectable von Willebrand factor (VWF) plasma levels, a recessive inheritance pattern, and heterogeneous genotype. The objective of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec67b9463a428c1d34effb2c7805a74
https://europepmc.org/articles/PMC8361454/
https://europepmc.org/articles/PMC8361454/
Autor:
Gabriella Hakim, B. Mesnard, Julien Branchereau, I. Chelghaf, Nicolas Drillaud, Arthur David, Jérôme Rigaud, Marc Trossaert, Marc Fouassier, Marianne Sigaud, Samuel Chelly, Marie-Aimée Perrouin Verbe, Catherine Ternisien, Stéphane De Vergie
Publikováno v:
Haemophilia. 27
Introduction To date, there is no specific recommendation or evaluation of the morbidity of prostate surgery in patients with haemophilia (PWH) although this surgery is common and at high risk of bleeding. Aim To assess the post-operative morbidity o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c4ae7f35db1df76d9c0f5d7471b5c7
https://doi.org/10.1111/hae.14388
https://doi.org/10.1111/hae.14388